LONDON, UNITED KINGDOM: 4th of January, 2024
Sanius Health, a leading London-based data, research, and personalised health patient AI platform, is excited to announce an exciting 10-year partnership with one of the UK’s largest primary care provider, Modality Partnership. The deal, valued at £225 million, represents a significant step forward in improving patient outcomes and delivering innovative healthcare solutions.
Under this transformative agreement, Sanius Health will provide its AI-enabled patient ecosystem to benefit over 500,000 patients across the United Kingdom. The partnership will see Modality Partnership leveraging Sanius Health's advanced AI and clinical services to offer patients enhanced coaching and clinical support within the Sanius Health patient data and personalised health ecosystem.
Dr Mina Gupta, Group Clinical Chair of Modality Partnership, expressed her enthusiasm, stating, "We have been doing some ground-breaking work in respiratory medicine with Sanius Health across the country and see this as a natural next step in our journey together. Delivering lasting changes in healthcare takes time. We look forward to the next phase of our relationship."
Vincent Sai, Group CEO and Partner of Modality Partnership, said “We are delighted to be partnering with Sanius to help patients living with life changing conditions.”
Orlando Agrippa, Founder and CEO of Sanius Health, commented, "It’s been a pleasure to work with the entire Modality family, and we look forward to 10 amazing years. We are ultra-passionate about improving outcomes for patients while accelerating access to novel data and personalised medicine technologies for clinical colleagues in research and supporting industry partners to improve evidence generation for drug approvals."
Every year, a significant number of new medicines undergo evaluation by the National Institute for Health and Care Excellence (NICE) and the US Food and Drug Administration (FDA) for approvals. Unfortunately, a substantial portion of these potential treatments—9 out of 37 (25%) —are rejected due to a lack of sufficient evidence regarding patient outcomes and unmet healthcare needs. Sanius Health aims to bridge this gap through its patient-consented data ecosystem, with a primary focus on improving patients' quality of life. By leveraging integrated, de-identified longitudinal datasets, Sanius Health accelerates the generation of real-world evidence (RWE) to support clinical trials, research, and patient care.
Sanius Health's innovative approach has already demonstrated remarkable results, significantly improving outcomes for patients while positively impacting healthcare systems. This includes a 52% reduction in Emergency department admissions, a 50% improvement in lengths of stay, and £16 million in cost savings in a single disease area.
About Sanius Health:
Sanius Health is an award-winning AI-powered digital data bank and patient ecosystem committed to enhancing patient outcomes, improving the quality of life, expediting evidence generation, research, and facilitating access to care for patients with haematological disorders, malignancies, rare diseases, and long-term medical conditions. By combining consented medical records, FDA-approved wearable technologies, DNA kits, quality-of-life data, and socioeconomic information, Sanius Health sets itself apart with a proprietary technology and data ownership model that is transforming healthcare.
About Modality Group:
Modality Partnership is an award-winning NHS GP super-partnership operating primary healthcare and community services on a national scale. This super-partnership comprises GP practices united under one partnership, allowing for more efficient and innovative healthcare delivery. Committed to NHS values, Modality focuses on growth, innovation, and sustaining services in General Practice and across the healthcare system. They aim to meet the growing needs and expectations of patients while maintaining continuity of care.
For press inquiries or more information, please contact: info@saniushealth.com
